A new way to use the empty shell of a hepatitis E virus has been developed to carry vaccines or drugs into the body. The technique has been tested in rodents as a way to target breast cancer, and is available for commercial licensing.
A new way to use the empty shell of a hepatitis E virus has been developed to carry vaccines or drugs into the body. The technique has been tested in rodents as a way to target breast cancer, and is available for commercial licensing.